InflaRx N.V. announced the appointment of Jan Medina, CFA, as Vice President and Head of Investor Relations of InflaRx. Mr. Medina brings over 25 years of extensive experience across the life sciences sector and capital markets, including in the areas of investor relations, communications and equity research. Jan joins InflaRx from Olink Proteomics where he was Vice President, Investor Relations & Capital Markets.

His previous IR experience includes roles at consultancy firms and at companies focused on oncology, immuno-oncology, hematology, specialty therapeutics and medical technology, ranging from early-stage ventures to global commercial entities. Jan?s sell-side experience includes roles within boutique and specialty research firms, as well as positions at several global investment banks. On the buy-side, Jan focused on healthcare and biotech.

He holds a Bachelor of Science in Biomedical Engineering from Tulane University School of Engineering and is a CFA charterholder.